Kelly Olino

Kelly Olino, MD, FACS, is an Assistant Professor of Surgery at Yale School of Medicine and a leading surgical oncologist specializing in skin cancer treatment. She serves as the Clinical Director of the Smilow Melanoma Program and Co-Director of the Cutaneous Malignancy Tumor Board at Yale Cancer Center.

• MD from Johns Hopkins School of Medicine (2005)
• Biological Sciences-Neurobiology BS from Cornell University (2000)
• Residency at Johns Hopkins Hospital (2013)
• Fellowship at Memorial Sloan Kettering Cancer Center (2015)

Dr. Olino's research focuses on immunotherapy for skin cancers, particularly melanoma and Merkel cell carcinoma, with translational work combining tumor immunology and clinical practice. Her recent publications examine immunotherapy resistance, metastatic patterns in melanoma, and novel treatment approaches for desmoid tumors.

Scientific awards include:

• Society for Surgical Oncology Clinical Investigator Award
• Calabresi Immune-Oncology Scholar Program
• Skin Cancer SPORE Career Enhancement Program
• Texas Rising Stars (2018)
• Golden Scalpel Medical Student Teaching Award (2016)
• Frank Coulson Resident Clinical Excellence Award (2013)

She actively participates in clinical trials for sarcoma treatments and serves on the NCCN non-melanoma cutaneous malignancy committee, emphasizing evidence-based practices for margin assessment in skin cancer surgeries.